Pfizer-BioNTech phase-III trial data shows high efficacy of a booster dose of their COVID-19 vaccine Read more
Valneva reports positive phase-III results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001 Read more
FDA approves Verzenio as the first and only CDK4/6 inhibitor for certain people with HR+HER2- high-risk early breast cancer Read more
Biological E seeks DCGI’s nod for phase-III trial of Corbevax as booster dose in those vaccinated with Covishield or Covaxin Read more